Abstract:ABSTRACT Staphylococcus aureus produces various hemolysins regulated by the Agr-QS system, except β-hemolysin encoded by the gene hlb . A classical laboratory S. aureus strain RN4220 displays only the β-hemolysin phenotype. It was suspected that the 8A mutation at the end of its agrA gene delayed the expressions of hla and RNAIII , then failed to express α- and δ-hemolysins. However, hla gene expression was detected at the later culture time without α-hemolysin phenotype, the reason for such a phenotype has not been clearly understood. We created hlb knockout and complementary mutants via homologous recombination in RN4220 and NRS049, two strains that normally produce β-hemolysin and carry agrA mutation. We found interestingly that the presence or absence of α-hemolysin phenotype in such strains depended on the expression of β-hemolysin instead of agrA mutations, which only inhibited δ-hemolysin expression. The hemolysis phenotype was verified by the Christie-Atkinson-Munch-Peterson (CAMP) test. Quantitative reverse transcription PCR was carried out to evaluate the relative gene expressions of hlb , hla , and RNAIII . The construction of mutants did not affect the agrA mutation status. We demonstrate that the absence of α-hemolysin in S. aureus RN4220 and NRS049 strains is attributed to their production of β-hemolysin instead of agrA mutation. Our findings broaden the understanding of the molecular mechanisms that control hemolysin expression in S. aureus that is crucial for the development of new therapeutic strategies to combat S. aureus infections. IMPORTANCE α-Hemolysin is a critical virulence factor in Staphylococcus aureus and its expression is largely controlled by the Agr-QS system. Nonetheless, the hemolysis phenotype and the regulation of the Agr-QS system in S. aureus still hold many mysteries. Our study finds that it is the expression of β- hemolysin rather than the agrA mutation that inhibits the function of the α-hemolysin in an important S. aureus strain RN4220 and a clinical strain presents a similar phenotype, which clarifies the misunderstood hemolytic phenotype and mechanism of S. aureus . Our findings highlight the interactions among different toxins and their biological roles, combined with QS system regulation, which is ultimately the true underlying cause of its virulence. This emphasizes the importance of considering the collaborative action of various factors in the infection process caused by this significant human pathogen.

Staphylococcus Aureus Α-Hemolysin Mutant H35A Inhibit Cytotoxicity of Wild Α-Hemolysin

Prokaryotic Expression and Identification of Hemolytic Activity of Staphylococcus aureus Hla Gene

Alpha-Hemolysin from Staphylococcus Aureus Obstructs Yeast-Hyphae Switching and Diminishes Pathogenicity in Candida Albicans

2,3-Dehydrokievitone combats methicillin-resistant <i>Staphylococcus aureus </i>infection by reducing alpha-hemolysin expression

2,3-Dehydrokievitone combats methicillin-resistant Staphylococcus aureus infection by reducing alpha-hemolysin expression

High hemolytic activity in Staphylococcus aureus t1081/ST45 due to increased Hla protein production and potential RNAIII-independent regulation

A Natural Dietary Flavone Myricetin as an α-Hemolysin Inhibitor for Controlling Staphylococcus aureus Infection

Subinhibitory Concentrations of Prim-O-Glucosylcimifugin Decrease the Expression of Alpha-Hemolysin in Staphylococcus Aureus (USA300)

Α-Hemolysin Suppresses Osteogenesis by Inducing Lipid Rafts Accumulation in Bone Marrow Stromal Cells

Subinhibitory Concentrations of Honokiol Reduce Α-Hemolysin (hla) Secretion by Staphylococcus Aureus and the Hla-induced Inflammatory Response by Inactivating the NLRP3 Inflammasome.

Two Residues in Staphylococcus Aureus Α-Hemolysin Related to Hemolysis and Self-Assembly

Aloe-emodin Attenuates Staphylococcus Aureus Pathogenicity by Interfering with the Oligomerization of Α-Toxin.

Electron beam irradiation degrades the toxicity and alters the protein structure of Staphylococcus aureus alpha-hemolysin

Identification of a Human Anti-Alpha-Toxin Monoclonal Antibody Against <i>Staphylococcus aureus</i> Infection

α-cyperone alleviates lung cell injury caused by Staphylococcus aureus via attenuation of α-hemolysin expression.

Identification of a Human Anti-Alpha-Toxin Monoclonal Antibody Against Staphylococcus aureus Infection

Genotypic Diversity Of Staphylococcus Aureus Alpha-Hemolysin Gene (Hla) And Its Association With Clonal Background: Implications For Vaccine Development

Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.

Inhibitory Effect of Andrographis Paniculata Lactone on Staphylococcus Aureus Α-Hemolysin

Phloretin Derived from Apple Can Reduce Alpha-Hemolysin Expression in Methicillin-Resistant Staphylococcus Aureus USA300

β-Hemolysin, not agrA mutation, inhibits the hemolysis of α-hemolysin in Staphylococcus aureus laboratory and clinical strains